Effect of repaglinide on the intestinal permeability of metformin hydrochloride in type 2 diabetic rats

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: GULSUN, Tugba (Hacettepe University, Faculty of Pharmacy Pharmaceutical Technology Department, ankara, Turkey)
  • Co-author(s): Tugba Gulsun: Faculty of Pharmacy Pharmaceutical Technology Department, Hacettepe University, Ankara, Turkey
    Selma Sahin: Faculty of Pharmacy Pharmaceutical Technology Department, Hacettepe University, ankara, Turkey
  • Abstract:

    Background

    Metformin hydrochloride (MH) is the first-line medication for type 2 diabetes. It is also used in combination with repaglinide (RG). To our knowledge, there is no study available in the literature in regard to intestinal permeability of MH in diabetes, and potential effect of RG on its permeability.

    Purpose

    The aim of this study was to

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login